Tiyazol-fenilasetik asit bileşiklerinin dual antibakteriyel-COX enzim inhibitörleri olarak sentezleri

Amaç: Bu çalışmanın amacı inflamasyon ve enfeksiyon geçiren hastalara önerilebilecek çift etkili potansiyel ilaçlar sunmak olup bu bağlamda tiyazol fenilasetik asit türevlerinin antienflamatuvar ve antibakteriyal aktiviteleri araştırmaktır.

Anahtar Kelimeler:

Inflamasyon, enfeksiyon, siklooksigenaz, antibakteriyal

Synthesis of thiazole-phenylacetic acid compounds as dual antibacterial-COX enzymes inhibitors

Purpose: Present a new potential dual drug for patient suffering both inflammation and infection was aim of this study therefore investigation of anti-inflammatory and antimicrobial activity of new thiazole-phenylacetic acid compounds derivatives as a potential dual drug was carried out.

Keywords:

Inflammation, infection, cyclooxygenases, antibacterial,

PDF

___

1. Cekici A, Kantarcı A, Hastürk H, Dyke TEV. Inflammatory and immune pathways in the pathogenesis of periodontal disease. Peridontol. 2000. 2014;64:57-60.
2. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860-7. 3. Amor S, Puentes F, Baker D, Valk P. Inflammation in neurodegenerative diseases. Immunology. 2010;129:154-69.
4. Libby P. Inflammation and cardiovascular disease. Am J Clin Nutr. 2006;83:456-60S.
5. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol. 2005;5:953-64.
6. Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell. 2010;140:771-6.
7. Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011;31:986-1000.
8. Ong CKS, Lirk P, Tan CH, Seymour RA. An evidence-based update on nonsteroidal antiinflammatory drugs. Clin Med Res. 2007;5:19-34.
9. Zaghi A, Arfaei S. Selective COX-2 Inhibitors: A review of their structure-activity relationship. Iran J Pharm Res. 2011;10:655-83.
10. Claria J. Cyclooxygenase-2 biolog. Curr Pharm Des. 2003;3:2177-90.
11. Bekhit AA, Abdel-Azeim T. Design, synthesis and biological evaluation of some pyrazole derivatives as anti-inflammatory-antimicrobial agents. Bioorg Med Chem. 2004;12:1935–45.
12. Ahmadi F, Ghayahbashi MR, Sharifzadeh M, Alipoiur E, Ostad SN, Vosooghi M, et al.. Synthesis and evaluation of anti-inflammatory and analgesic activities of new 1,2,4-triazole derivatives. Med Chem. 2015;11:69-76.
13. Bekhit AA, El-Sayed OA. Aboulmagd E, Park JY. Tetrazolo[1,5-a]quinoline as a potential promising new scaffold for the synthesis of novel antiinflammatory and antibacterial agents. Eur J Med Chem. 2004;39:249-55.
14. Moneer AA, Mohammed KO, El-Nassan HB. Synthesis of novel substituted thiourea and benzimidazole derivatives containing a pyrazolone ring as anti-inflammatory agents. Chem Biol Drug Des. 2016;87:784-93.
15. Paramashivappa R, Phani Kumar P, Subba Rao PV, Srinivasa Rao A. Design, synthesis and biological evaluation of benzimidazole/benzothiazole and benzoxazole derivatives as cyclooxygenase inhibitors. Bioorg Med Chem Lett. 2003;13:657-60.
16. Eswaran S, Adhikari AV, Shetty NS. Synthesis and antimicrobial activities of novel quinoline derivatives carrying 1,2,4-triazole moiety. Eur J Med Chem. 2009;44:4637–47.
17. Bekhit AA, Ashour HM, Abdel Ghany YS, Bekhit AD, Baraka A. Synthesis and biological evaluation of some thiazolyl and thiadiazole derivatives of 1Hpyrazole as anti-inflammatory antimicrobial agents. Eur J Med Chem. 2008;43:456-63.
18. [K548]Cyclooxygenase-1(COX-1) Inhibitor screening kit (Fluorometric) http://www.biovision.com/cyclooxygenase-1-cox-1- inhibitor-screening-kit-fluorometric.html (accessed Feb 2017).
19. [K547]Cyclooxygenase-2 (COX-2) Fluorescent Inhibitor Screening Kit (Fluorometric) http://www.biovision.com/cox-2-inhibitorscreening- kit-fluorometric.html (accessed Feb 2017).
20. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard-Ninth Edition. CLSI document M07-A9.
21. Sanchez-Borges M. Clinical management of nonsteroidal anti-inflammatory drug hypersensitivity. World Allergy Organ J. 2008;1:29-33.